Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2018-07-16 Interim / Quarterly Rep…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-June 2018. It contains comprehensive financial statements, including income statements, balance sheet summaries, cash flow analysis, and management commentary on business performance, risks, and outlook. It is not a mere announcement (RPA) as it provides full financial data and analysis for the specified period. H1 2018
2018-07-16 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report January - June 2018' and contains comprehensive financial statements, including income statements, balance sheet items, cash flow analysis, and management commentary for the specified period. It is clearly a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2018
2018-07-16 English
Biotage förlänger avtal med verkställande direktören Torben Jörgensen
Board/Management Information Classification · 98% confidence The document is a press release dated May 9, 2018, announcing that the Board of Directors of Biotage AB has agreed to extend the employment contract of the CEO, Torben Jörgensen, until April 2020. This announcement concerns a change in senior management/CEO tenure. Based on the definitions, this directly corresponds to 'Board/Management Information' (Code: MANG). The document is short and is an announcement, not a comprehensive report.
2018-05-09 Swedish
Biotage and CEO Torben Jörgensen have agreed to extend period of service
Board/Management Information Classification · 98% confidence The document is a short press release dated May 9, 2018, announcing that the Board of Directors and the CEO, Torben Jörgensen, have agreed to extend his employment contract until April 2020. This directly relates to a change in senior management personnel. Based on the definitions, this fits the 'Board/Management Information' category (Code: MANG). The document length is short (1455 chars) and it is the primary announcement, not a notice about another report, so RPA/RNS is not the primary fit.
2018-05-09 English
Resolutions at the Annual General Meeting in Biotage AB on April 26, 2018
AGM Information Classification · 100% confidence The document is explicitly titled "Resolutions at the Annual General Meeting in Biotage AB on April 26, 2018". It details decisions made regarding dividend appropriation, board member elections, auditor appointments, committee fees, and authorizations granted during the meeting. This content perfectly matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2018-04-27 English
Beslut vid årsstämman i Biotage AB den 27 april 2018
AGM Information Classification · 99% confidence The document is titled "Beslut vid årsstämman i Biotage AB den 27 april 2018" (Decisions at the Annual General Meeting in Biotage AB on April 27, 2018). It details specific resolutions passed at the meeting, including decisions on dividend distribution, granting discharge to the board, election of board members and chairman, appointment of auditors, setting board and committee remuneration, and authorizing the board to issue shares. These topics are central to the proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document length (4843 chars) is substantial enough to be the actual record of decisions, not just a brief announcement of the meeting itself.
2018-04-27 Swedish

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.